Answers are grounded in this paper and cite their sources.
Since the publication of the prior SCCT interpretation guidelines in 2014 (1), the use of coronary CT angiography (CCTA) has expanded substantially, with endorsement by multiple societies, a Class I recommendation for evaluation of coronary artery disease (CAD), and growing evidence supporting the prognostic value of coronary plaque characterization (2-9). Multi-energy CT is now clinically implemented, photon-counting detector CT (PCD-CT) is commercially available, and reporting has been standardized through CAD-RADS 2.0 (10-13).
No takes yet. Share an insight, caveat, or question.
Rajiah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: